“…This is particularly relevant in the setting of snakebite envenoming, in which patients often struggle to afford prolonged hospital admissions ( Schioldann et al, 2018 ; Harrison et al, 2009 ; Steinhorst et al, 2021 ; Arias-Rodríguez and Gutiérrez, 2020 ; Brown, 2012 ) and in which long-term follow-up, especially with regard to disability and morbidity, is notoriously challenging ( Aglanu et al, 2022 ; Brenes-Chacon et al, 2020 ; Jayawardana et al, 2016 ; Kasturiratne et al, 2021 ). Many patients and THs see promise in therapies offered at the hospital, most notably antivenom ( Chuat et al, 2021 ; Vaiyapuri et al, 2013 ; Steinhorst et al, 2021 ; Schurer et al, 2022 ). Strengthening collaborations with THs could spur a larger proportion of patients to seek care at the hospital for urgent and life-saving measures, while possibly relying on the less costly services of THs during their recuperation period.…”